Valiant Laboratories Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Valiant Laboratories Limited, at its meeting on July 9, 2025, approved a Rights Issue of fully-paid equity shares (face value Rs. 10) for an amount not exceeding Rs. 8,146.88 lakhs (approximately Rs. 81.47 crores). A Rights Issue Committee has been formed to decide the issue size, entitlement ratio, price, and record date. In a separate decision, the Board appointed Mr. Akshay Gangurde (ICSI Membership No. A70561) as the new Company Secretary and Compliance Officer, designated as a Key Managerial Personnel (KMP), effective July 9, 2025. He is an Associate Member of ICSI with over three years of experience in corporate governance and secretarial compliance, previously associated with S H Kelkar, Saregama India, and Makarand M. Joshi & Co.
The Rights Issue will raise capital for the company but will dilute existing shareholders' stakes, who will need to watch for the record date to participate or sell rights entitlement. The Company Secretary appointment is a routine governance change with no material impact on stock price.